XOMA Royalty (XOMA) EBT Margin Growth (5y) (2016 - 2026)
XOMA Royalty (XOMA) EBT Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,239.00 |
| Dec 31, 2025 | -1,546.00 |
| Jun 30, 2025 | 644,490.00 |
| Mar 31, 2025 | 131,598.00 |
| Dec 31, 2024 | -88,767.00 |
| Sep 30, 2024 | -27,548.00 |
| Jun 30, 2024 | -11,520.00 |
| Mar 31, 2024 | -76,352.00 |
| Dec 31, 2023 | -138,066.00 |
| Sep 30, 2023 | -508,284.00 |
| Jun 30, 2023 | -96,233.00 |
| Dec 31, 2022 | -71,116.00 |
| Sep 30, 2022 | -332,719.00 |
| Jun 30, 2022 | -396,738.00 |
| Mar 31, 2022 | 404,424.00 |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 116,590.00 |
| Jun 30, 2021 | 404,630.00 |
| Mar 31, 2021 | -158,776.00 |
| Dec 31, 2020 | 2,743.00 |